Home »
Academic Articles »
C »
Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma—a large-scale, multi-center, and retrospective study
Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma—a large-scale, multi-center, and retrospective study
Xiaohang Yang
(Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Jingjing Yin
(Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Yu Fu
(Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Yuanming Shen
(Women’s Hospital, School of Medicine, Zhejiang University)
Chuyao Zhang
(Department of Gynecologic Oncology, Sun Yat-Sen University Cancer Center)
Shuzhong Yao
(Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-Sen University)
Congjian Xu
(Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University)
Min Xia
(Department of Gynecology and Obstetrics, The Affiliated Yantai Yuhuangding Hospital of Qingdao University)
Ge Lou
(Department of Gynecology Oncology, Harbin Medical University Cancer Hospital)
Jihong Liu
(Department of Gynecologic Oncology, Sun Yat-Sen University Cancer Center)
Bei Lin
(Department of Obstetrics and Gynecology, Shengjing Hospital Affiliated to China Medical University)
Jianliu Wang
(Peking University People’s Hospital)
Weidong Zhao
(The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China)
Jieqing Zhang
(Department of Gynecologic Oncology, Guangxi Medical University Cancer Hospital)
Wenjun Cheng
(The First Affiliated Hospital of Nanjing Medical University)
Hongyan Guo
(The Third Hospital of Peking University)
Ruixia Guo
(Department of Gynecology and Obstetrics, The First Affiliated Hospital of Zhengzhou University)
Fengxia Xue
(Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital)
Xipeng Wang
(Department of Gynecology and Obstetrics, XinHua Hospital, Shanghai JiaoTong University School of Medicine)
Lili Han
(Department of Gynecology, People’s Hospital of Xinjiang Uygur Autonomous Region)
Xiaomao Li
(Department of Gynecology and Obstetrics, The Third Affiliated Hospital, Sun Yat-Sen University)
Ping Zhang
(Department of Gynecology, The Second Hospital of Shandong University)
Jianguo Zhao
(Department of Gynecologic Oncology, Tianjin Central Hospital of Gynecology and Obstetrics, Affiliated Hospital of Nankai University)
Wenting Li
(Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Yingyu Dou
(Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Zizhuo Wang
(Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Jingbo Liu
(Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Kezhen Li
(Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Gang Chen
(Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Chaoyang Sun
(Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Pengming Sun
(Fujian Provincial Women & Children’s Hospital, Fujian Provincial Maternity & Children Health Hospital, Fujian Medical University)
Weiguo Lu
(Women’s Hospital, School of Medicine, Zhejiang University)
Qin Yao
(Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University)
Abstract Introduction Myometrial invasion is a prognostic factor for lymph node metastases and decreased survival in non-endometrioid endometrial carcinoma patients. Herein, we explored the mode of myometrial invasion diagnosis in FIGO stage I non-endometrioid carcinoma and evaluated the differences in diagnostic efficiency among intraoperative frozen section (IFS), intraoperative gross examination (IGE), magnetic resonance imaging (MRI), and computed tomography (CT) in clinical practice. Finally, we suggested which test should be routinely performed. Method This was a historical cohort study nationwide with 30 centers in China between January 2000 and December 2019. Clinical data, including age, histology, method of myometrial invasion evaluation (MRI, CT, IGE, and IFS), and final diagnosis of postoperative paraffin sections, were collected from 490 non-endometrioid endometrial carcinoma (serous, clear cell, undifferentiated, mixed carcinoma, and carcinosarcoma) women in FIGO stage I. Results Among the 490 patients, 89.59% presented myometrial invasion. The methods reported for myometrial invasion assessment were IFS in 23.47%, IGE in 69.59%, MRI in 37.96%, and CT in 10.20% of cases. The highest concordance was detected between IFS and postoperative paraffin sections (Kappa = 0.631, accuracy = 93.04%), followed by IGE (Kappa = 0.303, accuracy = 82.40%), MRI (Kappa = 0.131, accuracy = 69.35%), and CT (Kappa = 0.118, accuracy = 50.00%). A stable diagnostic agreement between IFS and the final results was also found through the years (2000–2012: Kappa = 0.776; 2013–2014: Kappa = 0.625; 2015–2016: Kappa = 0.545; 2017–2019: Kappa = 0.652). Conclusion In China, the assessment of myometrial invasion in non-endometrioid endometrial carcinoma is often performed via IGE, but the reliability is relatively low in contrast to IFS. In clinical practice, IFS is a reliable method that can help accurately assess myometrial invasion and intraoperative decision-making (lymph node dissection or not). Hence, it should be routinely performed in non-endometrioid endometrial carcinoma patients.
Xiaohang Yang, Jingjing Yin, Yu Fu, et al. (2023). "Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma—a large-scale, multi-center, and retrospective study". Diagnostic Pathology. https://doi.org/10.1186/s13000-023-01294-z